open access
Measuring the QT interval on the go


- Cardiac Electrophysiology and Peri-Operative Medicine Division of Cardiology PhD Candidate, Health Research Methods, McMaster University, Hamilton, Ontario, Canada
- Division of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada
open access
Abstract
Abstract


Title
Measuring the QT interval on the go
Journal
Issue
Article type
Editorial
Pages
358-359
Published online
2021-05-25
Page views
549
Article views/downloads
599
DOI
Pubmed
Bibliographic record
Cardiol J 2021;28(3):358-359.
Authors
William F. McIntyre
Carlos A. Morillo


- Li G, Saguner AM, An J, et al. Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality. Cardiol J. 2020; 27(5): 616–624.
- Abellas-Sequeiros M, Lozano-Granero C, Garcia-Sebastian C, et al. Monitoring of QTc interval in patients with COVID-19. First experience with a portable ECG-recording device. Cardiol J. 2021 [Epub ahead of print].
- Horby P, Mafham M, Linsell L, et al. RECOVERY Collaborative Group. Effect of hydroxychloroquine in hospitalized patients with COVID-19. N Engl J Med. 2020; 383(21): 2030–2040.
- Cavalcanti AB, Zampieri FG, Rosa RG, et al. Hydroxychloroquine with or without azithromycin in mild-to-moderate COVID-19. N Engl J Med. 2020; 383(21): 2041–2052.
- Mitjà O, Corbacho-Monné M, Ubals M, et al. A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of COVID-19. N Engl J Med. 2021; 384(5): 417–427.
- Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N Engl J Med. 2020; 382(19): 1787–1799.
- Nachimuthu S, Assar MD, Schussler JM. Drug-induced QT interval prolongation: mechanisms and clinical management. Ther Adv Drug Saf. 2012; 3(5): 241–253.